IFN‐γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease

Cell‐based therapy for the treatment of inflammatory disorders has focused on the application of mesenchymal stromal cells (MSCs) and multipotent adult progenitor cells (MAPCs). Despite the recent positive findings in industry‐sponsored clinical trials of MSCs and MAPCs for graft vs host disease (Gv...

Descripción completa

Detalles Bibliográficos
Autores principales: Carty, Fiona, Dunbar, Hazel, Hawthorne, Ian J., Ting, Anthony E., Stubblefield, Samantha R., Van't Hof, Wouter, English, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Tissue‐specific Progenitor and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550699/
https://www.ncbi.nlm.nih.gov/pubmed/34397170
http://dx.doi.org/10.1002/sctm.21-0008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550699/
https://www.ncbi.nlm.nih.gov/pubmed/34397170
http://dx.doi.org/10.1002/sctm.21-0008

Ejemplares similares